313 related articles for article (PubMed ID: 15250020)
41. Controversies in the management of fever in the neutropenic cancer patient.
Seftel MD
Transfus Apher Sci; 2010 Apr; 42(2):151-6. PubMed ID: 20106722
[TBL] [Abstract][Full Text] [Related]
42. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
Girmenia C; Russo E; Carmosino I; Breccia M; Dragoni F; Latagliata R; Mecarocci S; Morano SG; Stefanizzi C; Alimena G
Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
[TBL] [Abstract][Full Text] [Related]
43. The place for itraconazole in treatment.
Maertens J; Boogaerts M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
[TBL] [Abstract][Full Text] [Related]
44. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
Ritchie S; Palmer S; Ellis-Pegler R
Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
[TBL] [Abstract][Full Text] [Related]
45. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
Przepiorka D; Buadi FK; McClune B
Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
[TBL] [Abstract][Full Text] [Related]
46. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia.
Baskaran ND; Gan GG; Adeeba K; Sam IC
Int J Infect Dis; 2007 Nov; 11(6):513-7. PubMed ID: 17459753
[TBL] [Abstract][Full Text] [Related]
47. Treatment of patients with hematologic neoplasm, fever, and neutropenia.
Sepkowitz KA
Clin Infect Dis; 2005 Apr; 40 Suppl 4():S253-6. PubMed ID: 15768331
[TBL] [Abstract][Full Text] [Related]
48. [Management of microbial infections in myeloid leukemia].
Monma F; Katayama N
Nihon Rinsho; 2009 Oct; 67(10):1969-73. PubMed ID: 19860199
[TBL] [Abstract][Full Text] [Related]
49. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
[TBL] [Abstract][Full Text] [Related]
50. [Empirical antimicrobial therapy in neutropenic patients].
Maschmeyer G
Ther Umsch; 1996 Nov; 53(11):854-62. PubMed ID: 8984691
[TBL] [Abstract][Full Text] [Related]
51. [Therapy of bacterial infections in neutropenic and immunocompromised patients].
Helbig W; Tauchnitz R
Z Gesamte Inn Med; 1992 Sep; 47(9):417-21. PubMed ID: 1441670
[TBL] [Abstract][Full Text] [Related]
52. Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin.
Martino R; Viscoli C
Br J Haematol; 2006 Jan; 132(2):138-54. PubMed ID: 16398648
[TBL] [Abstract][Full Text] [Related]
53. Prophylaxis and treatment of bacterial infections: do we need new strategies?
Micozzi A; Bucaneve G
Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
[TBL] [Abstract][Full Text] [Related]
54. [Infections in immunosuppressed children].
Wiger K; Høiby EA; Wathne KO
Tidsskr Nor Laegeforen; 2005 May; 125(9):1168-72. PubMed ID: 15880153
[TBL] [Abstract][Full Text] [Related]
55. Antimicrobial chemoprophylaxis in immunocompromised patients.
Frøland SS
Scand J Infect Dis Suppl; 1990; 70():130-40. PubMed ID: 2287895
[TBL] [Abstract][Full Text] [Related]
56. Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies.
Feld R; Paesmans M; Freifeld AG; Klastersky J; Pizzo PA; Rolston KV; Rubenstein E; Talcott JA; Walsh TJ; ;
Clin Infect Dis; 2002 Dec; 35(12):1463-8. PubMed ID: 12471564
[TBL] [Abstract][Full Text] [Related]
57. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2008.
Slavin MA
Intern Med J; 2008 Jun; 38(6b):457-67. PubMed ID: 18588519
[TBL] [Abstract][Full Text] [Related]
58. An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.
Glasmacher A; von Lilienfeld-Toal M; Schulte S; Hahn C; Schmidt-Wolf IG; Prentice A
Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():17-23. PubMed ID: 16138815
[TBL] [Abstract][Full Text] [Related]
59. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
60. [Empirical antibiotic therapy for febrile neutropenia].
Kridel R; Van Delden C; Calandra T; Marchetti O
Rev Med Suisse; 2008 Apr; 4(152):914, 916-9. PubMed ID: 18578432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
